A citation-based method for searching scientific literature

Angus Toland, Kristin Huntoon, Sonika M Dahiya. Neurosurgery 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
259
100

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma.
Daijun Wang, Shuchen Sun, Lingyang Hua, Jiaojiao Deng, Shihai Luan, Haixia Cheng, Qing Xie, Hiroaki Wakimoto, Hongda Zhu, Ye Gong. Front Oncol 2020
4
100

Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Ansley Unterberger, Thien Nguyen, Courtney Duong, Aditya Kondajji, Daniel Kulinich, Isaac Yang. J Neurooncol 2021
4
100


Artificial intelligence neuropathologist for glioma classification using deep learning on hematoxylin and eosin stained slide images and molecular markers.
Lei Jin, Feng Shi, Qiuping Chun, Hong Chen, Yixin Ma, Shuai Wu, N U Farrukh Hameed, Chunming Mei, Junfeng Lu, Jun Zhang,[...]. Neuro Oncol 2021
7
100

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
Annamaria Biczok, Theo Kraus, Bogdana Suchorska, Nicole A Terpolilli, Jun Thorsteinsdottir, Armin Giese, Joerg C Tonn, Christian Schichor. J Neurooncol 2018
35
100

Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence.
Anil Nanda, Shyamal C Bir, Subhas Konar, Tanmoy Maiti, Piyush Kalakoti, Jamie A Jacobsohn, Bharat Guthikonda. J Clin Neurosci 2016
37
100

High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.
C Leland Rogers, Minhee Won, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, Shannon E Fogh, Emad Youssef,[...]. Int J Radiat Oncol Biol Phys 2020
40
100

Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
S-Y Yang, C-K Park, S-H Park, D G Kim, Y S Chung, H-W Jung. J Neurol Neurosurg Psychiatry 2008
178
100

Efficacy of postoperative radiotherapy for high grade meningiomas.
Yunseon Choi, Do Hoon Lim, Kyungil Jo, Do-Hyun Nam, Ho Jun Seol, Jung-Il Lee. J Neurooncol 2014
24
100

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.
Christian Koelsche, Felix Sahm, David Capper, David Reuss, Dominik Sturm, David T W Jones, Marcel Kool, Paul A Northcott, Benedikt Wiestler, Katja Böhmer,[...]. Acta Neuropathol 2013
199
100

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.
Sabine Spiegl-Kreinecker, Daniela Lötsch, Katharina Neumayer, Lucia Kastler, Johannes Gojo, Christine Pirker, Josef Pichler, Serge Weis, Rajiv Kumar, Gerald Webersinke,[...]. Neuro Oncol 2018
51
100

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
474
100

Molecular alterations in meningioma: prognostic and therapeutic perspectives.
Cristina Birzu, Matthieu Peyre, Felix Sahm. Curr Opin Oncol 2020
11
100

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.
Tareq A Juratli, Devin McCabe, Naema Nayyar, Erik A Williams, Ian M Silverman, Shilpa S Tummala, Alexandria L Fink, Aymen Baig, Maria Martinez-Lage, Martin K Selig,[...]. Acta Neuropathol 2018
39
100

BAP1 mutations in high-grade meningioma: implications for patient care.
Ganesh M Shankar, Sandro Santagata. Neuro Oncol 2017
77
100

Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
Varun R Kshettry, Quinn T Ostrom, Carol Kruchko, Ossama Al-Mefty, Gene H Barnett, Jill S Barnholtz-Sloan. Neuro Oncol 2015
98
100

Genetic landscape of meningioma.
Sayaka Yuzawa, Hiroshi Nishihara, Shinya Tanaka. Brain Tumor Pathol 2016
65
100

Radiotherapy for atypical meningiomas.
Richard Mair, Kevin Morris, Ian Scott, Thomas A Carroll. J Neurosurg 2011
119
100

A Practical Overview on the Molecular Biology of Meningioma.
Pedro David Delgado-López, Esther Cubo-Delgado, Jerónimo Javier González-Bernal, Javier Martín-Alonso. Curr Neurol Neurosci Rep 2020
7
100

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
166
100

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.
Christian Mirian, Anne Katrine Duun-Henriksen, Tareq Juratli, Felix Sahm, Sabine Spiegl-Kreinecker, Matthieu Peyre, Annamaria Biczok, Jörg-Christian Tonn, Stéphane Goutagny, Luca Bertero,[...]. J Neurol Neurosurg Psychiatry 2020
33
100

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
Raymond Y Huang, Wenya Linda Bi, Michael Weller, Thomas Kaley, Jaishri Blakeley, Ian Dunn, Evanthia Galanis, Matthias Preusser, Michael McDermott, Leland Rogers,[...]. Neuro Oncol 2019
53
100

TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
185
100

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
100

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
100

EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
368
100

Common genetic variations of deiodinase genes and prognosis of brain tumor patients.
Adomas Bunevicius, Edward R Laws, Ausra Saudargiene, Arimantas Tamasauskas, Giorgio Iervasi, Vytenis Deltuva, Timothy R Smith, Robertas Bunevicius. Endocrine 2019
3
100

Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.
T W Dziuk, S Woo, E B Butler, J Thornby, R Grossman, W S Dennis, H Lu, L S Carpenter, J K Chiu. J Neurooncol 1998
187
100

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.
Quinn T Ostrom, Haley Gittleman, Peter Liao, Chaturia Rouse, Yanwen Chen, Jacqueline Dowling, Yingli Wolinsky, Carol Kruchko, Jill Barnholtz-Sloan. Neuro Oncol 2014
946
100

Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Hongda Zhu, Wenya Linda Bi, Ayal Aizer, Lingyang Hua, Mi Tian, Jiaojiao Den, Hailiang Tang, Hong Chen, Yin Wang, Ying Mao,[...]. Cancer Med 2019
25
100

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
Stéphane Goutagny, Jean C Nault, Maxime Mallet, Dominique Henin, Jessica Z Rossi, Michel Kalamarides. Brain Pathol 2014
157
100

An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
Sam Q Sun, Ammar H Hawasli, Jiayi Huang, Michael R Chicoine, Albert H Kim. Neurosurg Focus 2015
79
100

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
322
100

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.
Matthieu Peyre, Guillaume Gauchotte, Marine Giry, Sébastien Froehlich, Johan Pallud, Thomas Graillon, Franck Bielle, Dominique Cazals-Hatem, Pascale Varlet, Dominique Figarella-Branger,[...]. Neuro Oncol 2018
41
100

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas.
Philipp Sievers, Thomas Hielscher, Daniel Schrimpf, Damian Stichel, David E Reuss, Anna S Berghoff, Marian C Neidert, Hans-Georg Wirsching, Christian Mawrin, Ralf Ketter,[...]. Acta Neuropathol 2020
28
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.